Harvard University

Harvard is currently collaborating with a number of institutions that are researching psychedelics. In 2021, the Center for the Neuroscience of Psychedelics was launched at Massachusetts General Hospital in collaboration with Harvard Medical School. The Center seeks to understand how psychedelics enhance the brain’s capacity for change, optimize current treatments and create new treatments for mental illness, and make the term “treatment-resistant” obsolete.

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School has begun a three-year research initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. The Project on Psychedelics Law and Regulation (POPLAR) will focus on promoting safety, innovation, and equity in psychedelics research, commerce, and therapeutics. POPLAR is the first academic initiative focused on this particular aspect of psychedelic science.

Company Information

Harvard University Website

June, 2021


Research Institute

Topics of Interest
Equity and Ethics Neuroscience

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships

Related Course(s)

Psychedelic-Assisted Psychotherapy: The Next Frontier
Psychedelic-Assisted Psychotherapy: The Next Frontier, offers healthcare professionals a comprehensive overview of the emerging field of PAP.


HQ / Office Cambridge, MA 02138, USA